<DOC>
	<DOCNO>NCT01395069</DOCNO>
	<brief_summary>Assess prophylactic efficacy topical non-steroidal anti-inflammatory drop prevent macular edema . Patient undergo uncomplicated cataract surgery enrol randomize nepafenac , ketorolac , placebo . Follow-up occur 1 month ocular coherence tomography ( OCT ) .</brief_summary>
	<brief_title>Prophylactic Nepafenac Ketorolac Versus Placebo Patients Undergoing Cataract Surgery</brief_title>
	<detailed_description />
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<mesh_term>Nepafenac</mesh_term>
	<criteria>Ability give inform consent Age 18 year old Any preexist retinal disease ( e.g. , diabetic retinopathy , vein occlusion , exudative macular degeneration , etc . ) Previous uveitis Previous intraocular surgery Allergy hypersensitivity NSAIDs Complicated cataract surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Post-cataract surgery</keyword>
	<keyword>macular edema</keyword>
</DOC>